Nitrate resistance in platelets from patients with stable angina pectoris

Circulation

Volumn 100, Issue 2, 1999, Pages 129-134

  Chirkov, Yuliy Y ^b   Holmes, Andrew S ^b   Chirkova, Larissa P ^b   Horowitz, John D ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b NONE

Author keywords

Angina; Nitroglycerin; Platelet Aggregation inhibitors

Indexed keywords

1H [1,2,4]OXADIAZOLO[1,3 A]QUINOXALIN 1 ONE; ADENOSINE DIPHOSPHATE; CATALASE; CYCLIC GMP; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; QUINOXALINE DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 0033551489     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.2.129     Document Type: Article

References (28)

1. Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: stenosis vasodilation as a major component of the drug response. Circulation. 1981;64:1089-1097.
2. Harrison DG, Bates JN. The nitrovasodilators: new ideas about old drugs. Circulation. 1993;87:1461-1467.
3. Diodati J, Theroux P, Latour J-G, Lacoste L, Lam JYT, Waters D. Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction. Am J Cardiol. 1990;66: 683-688.
4. Chirkov YY, Naujalis JI, Barber S, Sage RE, Gove DW, Brealey JK, Horowitz JD. Reversal of human platelet aggregation by low concentrations of nitroglycerin in vitro in normal subjects. Am J Cardiol. 1992; 70:802-806.
5. Parker JO. Nitrates and angina pectoris. Am J Cardiol. 1993;72:3C-8C.
6. Chirkov YY, Chirkova LP, Horowitz JD. Nitroglycerin tolerance at the platelet level in patients with angina pectoris. Am J Cardiol. 1997;80: 128-131.
7. Abrams J. The mystery of nitrate resistance. Am J Cardiol. 1991;68: 1393-1396.
8. Chirkov YY, Naujalis JI, Sage RE, Horowitz JD. Antiplatelet effects of nitroglycerin in healthy subjects and in patients with stable angina pectoris. J Cardiovasc Pharmacol. 1993;21:384-389.
9. Chirkov YY, Chirkova LP, Horowitz JD. Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris. Naunyn Schmiedebergs Arch Pharmacol. 1996;354:520-525.
10. Anderson TJ, Meredith IT, Ganz P, Selwyn AP, Yeung AC. Nitric oxide and nitrovasodilators: similarities, differences and potential interactions. J Am Coll Cardiol. 1994;24:555-566.
11. Feelisch M, Noack E. Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron. Eur J Pharmacol. 1987;142:465-469.
12. Bates JN, Baker MT, Guerra R, Harrison DG. Nitric oxide generation from nitroprusside by vascular tissue: evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol. 1991;42:S157-S165.
13. Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease: relevance in superoxide anion generation. Circulation. 1994;90:694-699.
14. Siminiak T, Zozulinska D, Zeromska M, Wysocki H. Evidence for plasma-mediated neutrophil superoxide anion production during myocardial infarction. Cardiology. 1993;82:377-382.
15. Riesenberg K, Levy R, Katz A, Galkop S, Schlaeffer F. Neutrophil superoxide release and interleukin 8 in acute myocardial infarction. Eur J Clin Invest. 1997;27:398-404.
16. Diodati JG, Cannon RO, Hussain N, Quyyumi AA. Inhibitory effect of nitroglycerin and sodium nitroprusside on platelet activation across the coronary circulation in stable angina pectoris. Am J Cardiol. 1995;75: 443-448.
17. Kinlough-Rathbone RL, Packham MA, Mustard JF. Platelet aggregation. In: Harker LA, Zimmerman TS, eds. Measurements of Platelet Function. New York: Churchill Livingstone; 1983:64-91.
18. Gyllenhammar H. Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J Immunol Methods. 1987;97: 209-213.
19. Moro MA, Russel RJ, Cellek S, Lizasoain I, Su Y, Darley-Usmar VM, Radomski MW, Moncada S. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci U S A. 1996;93:1480-1485.
20. Iuliano L, Colavita AR, Leo R, Pratico D, Violi F. Oxygen free radicals and platelet activation. Free Radic Biol Med. 1997;22:999-1006.
21. Leo R, Pratico D, Iuliano L, Pulcinelli FM, Ghiselli A, Pignatelli P, Colavita AR, FitzGerald GA, Violi F. Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenation. Circulation. 1997;95: 885-891.
22. Waldman SA, Murad F. Cyclic GMP synthesis and function. Pharmacol Rev. 1987;39:163-196.
23. Kamisaki Y, Waldman SA, Murad F. The involvement of catalytic site thiol groups in the activation of soluble guanylate cyclase by sodium nitroprusside. Arch Biochem Biophys. 1986;251:709-714.
24. Brune B, Schmidt KU, Ullrich V. Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur J Biochem. 1990;192:683-688.
25. Yao SK, Ober JC, Gonenne A, Clubb FJ, Krishnaswami A, Ferguson JJ, Anderson HV, Gorecki M, Buja LM, Willerson JT. Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries. Circ Res. 1993;73:952-967.
26. Forster W. Effect of various agents on prostaglandin biosynthesis and the anti-aggregatory effect. Acta Med Scand. 1980;642:35-46.
27. Mehta J, Mehta P, Roberts A, Faro R, Ostrowski N, Brigmon L. Comparative effects of nitroglycerin and nitroprusside on prostacyclin generation in adult human vessel wall. J Am Coll Cardiol. 1983;2: 625-630.
28. Folts JD, Stamler J, Loscalzo J. Intravenous nitroglycerin infusion inhibits cyclic blood flow responses caused by periodic platelet thrombus formation in stenosed canine coronary arteries. Circulation. 1991;83: 2122-2127.